Midlife activity linked to lower brain-related markers in men
Higher versus lower midlife activity was linked to lower levels of two blood proteins, with standardized associations of negative 0.10 and negative 0.08.
Our read
Populations- Studied:
- Cohort study of 564 male military veterans, 11.4 years
- What changed:
- Higher midlife activity was linked to lower levels of neurofilament light chain and glial fibrillary acidic protein
- The catch:
- Activity reports covered only the preceding week
- In the record:
- The 3,118th paper on physical activity with results in people; 7,216 on record in all. Its result on GFAP agrees with 2 of 3 other findings on record; 1 points the other way.
Editor of record: Boris Djordjevic · AgingResearch.News
The 564 male twins in this prospective observational study were military veterans aged 51–61 with no cognitive impairment at baseline. They reported the previous week's physical activity at about ages 56 and 67. Researchers measured Alzheimer's-related blood proteins at about 67, after an average follow-up of 11.4 years.
Higher midlife activity was linked to lower levels of neurofilament light chain, a marker of nerve-cell damage, and glial fibrillary acidic protein, a marker of brain support-cell activation. The associations used standardized scores, which put different measurements on a common scale. Activity at 56 was not significantly associated with measures of amyloid or tau, proteins involved in Alzheimer's disease.
Why it matters
Midlife physical activity may reduce the risk of nerve-cell deterioration in older age through mechanisms independent of amyloid, the authors suggested.
Caveats
Activity reports covered only the preceding week, and more active men may have been healthier in ways the analysis did not capture. The findings concern blood markers, not dementia prevention, and may not apply to women or people with cognitive impairment.
Exercise is part of Bryan Johnson's Blueprint
The paper
Prospective study on physical activity and Alzheimer's disease-related biomarkers
University of Helsinki; University of California San Diego
Alzheimer's & Dementia, Aug 2026, Open access



Comments
Be the first to comment.